CRO Services - ACTG-CRO
Bioequivalence studies are required for the Market Authorization Submission in Tunisia and african countries from Pharmaceutical companies producing generics who want to have the medicines distributed and sold in the african continent.
At ACTG-CRO, we provide you a dedicated Bioequivalence Site Partner WHO certified to run your studies under our supervision and management for a successful result.
Our Site Partner is a WHO-ACCREDITed AND CLEARED USFDA WITH NIL 483Bioequivalence Center
With ACTG-CRO, your Company receives the results and reports of your Bioequivalence Studies within 60 days once our Center Partner receives the reference products.
ACTG-CRO offers to Pharmaceutical Companies, a full-packaging from Bioequivalence Studies to the registration of their products in Africa and in Middle-Eastern countries with the distribution and promotion of their products. Please see what ACTG-CRO's services within our Pharmaceutical Marketing Department, by clikcing the link below:
Please Contact us and start your Bioequivalence Studies with us to let you expand your Business in Africa and in Middle-Eastern countries with our wide network.
Clinical Research, Tunisia, Africa, Clinical Trials, CRA, SCRA, Clinical Research Associate, GCP, Monitor, Monitoring, Senior Clinical Research Associate, CRA I, CRA II, CRA III, LCRA, Oncology, Cardiovascular, Neuroscience, Immunology, Infectious Diseases, Metabolism, Field Based, Home Based, CRO, Pharmaceutical